Rapid Micro Biosystems Inc (RPID)
$0.67
Performance
- $0.67$0.70$0.67
0.0%
Downside
Day's Volatility :4.29%
Upside
4.29%
- $0.58$1.19$0.67
13.43%
Downside
52 Weeks Volatility :51.26%
Upside
43.7%
Returns
| Period | Rapid Micro Biosystems Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -27.56% | 6.5% | 0.0% |
6 Months | -29.38% | 7.1% | 0.0% |
1 Year | -34.13% | 9.8% | 0.0% |
3 Years | -96.62% | 14.2% | -20.2% |
Highlights
Market Capitalization | 28.5M |
Book Value | $2.48 |
Earnings Per Share (EPS) | -1.21 |
PEG Ratio | 0.0 |
Wall Street Target Price | 4.75 |
Profit Margin | -224.73% |
Operating Margin TTM | -254.38% |
Return On Assets TTM | -23.24% |
Return On Equity TTM | -40.17% |
Revenue TTM | 23.1M |
Revenue Per Share TTM | 0.54 |
Quarterly Revenue Growth YOY | 11.4% |
Gross Profit TTM | -8.5M |
EBITDA | -53.1M |
Diluted Eps TTM | -1.21 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.09 |
EPS Estimate Next Year | -1.01 |
EPS Estimate Current Quarter | -0.29 |
EPS Estimate Next Quarter | -0.29 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 608.96%
Technicals Summary
Sell
Neutral
Buy
Rapid Micro Biosystems Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Rapid Micro Biosystems Inc | -5.52% | -29.38% | -34.13% | -96.62% | -96.8% |
 Stryker Corporation | -3.84% | 5.16% | 12.86% | 24.25% | 52.69% |
 Boston Scientific Corp. | -3.68% | 21.48% | 41.72% | 68.89% | 76.47% |
 Edwards Lifesciences Corp. | -34.8% | -18.49% | -34.85% | -45.17% | -15.86% |
 Abbott Laboratories | 1.03% | -5.4% | -7.12% | -11.35% | 20.75% |
 Medtronic Plc | -1.99% | -9.34% | -13.21% | -38.74% | -23.49% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Rapid Micro Biosystems Inc | 6.68 | NA | 0.0 | -1.09 | -0.4 | -0.23 | NA | 2.48 |
Stryker Corporation | 38.91 | 38.91 | 2.92 | 11.95 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.22 | 63.22 | 1.8 | 2.37 | 0.09 | 0.05 | NA | 13.16 |
Edwards Lifesciences Corp. | 36.4 | 36.4 | 5.19 | 2.76 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 33.84 | 33.84 | 5.99 | 4.66 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 28.97 | 28.97 | 1.52 | 5.2 | 0.07 | 0.04 | 0.04 | 38.29 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Rapid Micro Biosystems Inc | Buy | $28.5M | -96.8% | 6.68 | -224.73% |
Stryker Corporation | Buy | $129.7B | 52.69% | 38.91 | 16.03% |
Boston Scientific Corp. | Buy | $114.3B | 76.47% | 63.22 | 12.05% |
Edwards Lifesciences Corp. | Buy | $52.4B | -15.86% | 36.4 | 23.74% |
Abbott Laboratories | Buy | $186.6B | 20.75% | 33.84 | 13.65% |
Medtronic Plc | Buy | $102.5B | -23.49% | 28.97 | 11.36% |
Insights on Rapid Micro Biosystems Inc
Decreasing Revenue
Revenue is down for the last 3 quarters, 6.33M → 5.61M (in $), with an average decrease of 5.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -11.17M → -13.32M (in $), with an average decrease of 9.6% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 41.7% return, outperforming this stock by 75.8%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 68.9% return, outperforming this stock by 165.5%
Institutional Holdings
Bain Capital Life Sciences Investors, LLC
19.68%Kennedy Lewis Management LP
11.53%Glenview Capital Management LLC
3.08%ABG-WTT Global Life Science Capital Partners GP Ltd
2.42%BlackRock Inc
2.38%Vanguard Group Inc
1.70%
Company Information
rapid micro biosystems provides innovative products for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology and personal care products. the company's growth direct(tm) system detects contamination earlier, delivering compelling economic benefits to manufacturers while improving their quality process. the growth direct(tm) system is the first and only automated system that accelerates testing while fitting with current regulatory practices and addressing all key applications.
Organization | Rapid Micro Biosystems Inc |
Employees | 193 |
CEO | Mr. Robert G. Spignesi Jr. |
Industry | Healthcare |
